» Articles » PMID: 6427766

Chromosomal Assignment of the Gene for Human Elongation Factor 2

Overview
Specialty Science
Date 1984 May 1
PMID 6427766
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Elongation factor 2 (EF-2), polypeptidyl -tRNA translocase, is an essential factor for protein synthesis in eukaryotic cells and Archebacteria . We isolated diphtheria toxin-resistant human primary embryo cells that contain EF-2 that cannot be ADP-ribosylated by diphtheria toxin and Pseudomonas exotoxin A (PA toxin). Somatic cell hybrids were constructed from mouse L cells and toxin-resistant human embryo cell mutants. Forty-one hybrid clones were isolated, of which 15 clones were resistant to PA toxin. Karyotypic analysis and isozyme studies revealed that there was an absolute correlation between human chromosome 19 and resistance to PA toxin in the hybrids. On subcloning of PA toxin-resistant hybrid cells, we obtained one PA toxin-resistant hybrid subclone containing human chromosome 19 as the only human chromosome. Furthermore, the resistance to PA toxin of hybrid cell strains was lost after infection with poliovirus, for which sensitivity is conferred by human chromosome 19. It was confirmed by using two-dimensional gel electrophoresis that PA toxin resistance in hybrid cells was caused by the presence of EF-2 resistant to ADP-ribosylation by fragment A of diphtheria toxin. These facts suggest that the gene encoding EF-2 is located on human chromosome 19.

Citing Articles

A novel de novo variant in CASK causes a severe neurodevelopmental disorder that masks the phenotype of a novel de novo variant in EEF2.

Rodriguez-Garcia M, Cotrina-Vinagre F, Olson A, Sanchez-Calvin M, Martinez de Aragon A, de Las Heras R J Hum Genet. 2023; 68(8):543-550.

PMID: 37072624 DOI: 10.1038/s10038-023-01150-4.


A novel DPH5-related diphthamide-deficiency syndrome causing embryonic lethality or profound neurodevelopmental disorder.

Shankar S, Grimsrud K, Lanoue L, Egense A, Willis B, Horberg J Genet Med. 2022; 24(7):1567-1582.

PMID: 35482014 PMC: 9426662. DOI: 10.1016/j.gim.2022.03.014.


Identification of a novel mutation in with functional analysis in a cohort of 516 familial patients with exudative vitreoretinopathy.

Wang K, Zhang X, Tian T, Zhao P Mol Vis. 2021; 27:528-541.

PMID: 34526760 PMC: 8410233.


Exosome-mediated transfer of CD44 from high-metastatic ovarian cancer cells promotes migration and invasion of low-metastatic ovarian cancer cells.

Shen X, Wang C, Zhu H, Wang Y, Wang X, Cheng X J Ovarian Res. 2021; 14(1):38.

PMID: 33627162 PMC: 7905574. DOI: 10.1186/s13048-021-00776-2.


A high-throughput screening assay for eukaryotic elongation factor 2 kinase inhibitors.

Xiao T, Liu R, Proud C, Wang M Acta Pharm Sin B. 2016; 6(6):557-563.

PMID: 27818922 PMC: 5071636. DOI: 10.1016/j.apsb.2016.04.002.


References
1.
Mekada E, Uchida T, Okada Y . Modification of the cell surface with neuraminidase increases the sensitivities of cells to diphtheria toxin and Pseudomonas aeruginosa exotoxin. Exp Cell Res. 1979; 123(1):137-46. DOI: 10.1016/0014-4827(79)90430-0. View

2.
Uchida T, Kim J, Yamaizumi M, Miyake Y, Okada Y . Reconstitution of lipid vesicles associated with HVJ (Sendai virus) sikes. Purification and some properties of vesicles containing nontoxic fragment A of diphtheria toxin. J Cell Biol. 1979; 80(1):10-20. PMC: 2110294. DOI: 10.1083/jcb.80.1.10. View

3.
Moehring T, Danley D, Moehring J . Codominant translational mutants of Chinese hamster ovary cells selected with diphtheria toxin. Somatic Cell Genet. 1979; 5(4):469-80. DOI: 10.1007/BF01538881. View

4.
Draper R, Chin D, Scheffler I, Simon M . Biochemical and genetic characterization of three hamster cell mutants resistant to diphtheria toxin. J Cell Biol. 1979; 83(1):116-25. PMC: 2110445. DOI: 10.1083/jcb.83.1.116. View

5.
Van Ness B, Howard J, BODLEY J . ADP-ribosylation of elongation factor 2 by diphtheria toxin. NMR spectra and proposed structures of ribosyl-diphthamide and its hydrolysis products. J Biol Chem. 1980; 255(22):10710-6. View